Christmas Eve, 1912: The pharmaceutical company Merck files for a patent on MDMA (‘ecstasy’)

What is Molly?MDMA (often called ‘Molly’ or ‘ecstasy’) has become one of America’s favorite drugs since the 1980s, when it ‘escaped’ from the world of professional MDMA therapy and became popular among partiers.  Usually taken as pills or capsules, the drug typically produces an energetic high with a profound sense of peace and joy that …

As the feds crack down on opioid prescriptions, patients are taking their own lives, doctors are losing their jobs and overdose rates continue unabated.

The Government’s Solution To The Opioid     Crisis Feels Like A War To Pain PatientsBy Art LevineJay Lawrence, an energetic truck driver in his late 30s, was driving a semitrailer across a bridge when the brakes failed. To avoid plowing into the car in front of him, he swerved sideways and slammed the truck into a …

Bayer completes $63-billion Monsanto takeover

AFP|Updated: Jun 07, 2018, 06.58 PM ISTFRANKFURT AM MAIN: German chemicals and pharmaceuticals giant BayerNSE 0.00 % said Thursday its two-year pursuit of US-based MonsantoNSE 1.01 % was over, as the two firms signed off a $63-billion merger deal. "Shares in the US company will no longer be traded on the New York Stock Exchange, …

Cannabis, CBD industry wary of looming decision on epilepsy drug

Published April 9, 2018 | By Kristen NicholsThe most disruptive product to hit the newly legal hemp industry might be one that will never be sold directly to consumers.GW Pharmaceuticals, a London-based biotech company, is awaiting a final decision from the U.S. Food and Drug Administration to produce the first cannabis-derived treatment to win approval …

“Your son is on CBD oil. He is terminated from the clinical trial. Don’t bother ever showing up again,”

13-Year-Old Denied Life-Saving Treatment Because He Used CBD OilMarch 5, 2018 By Burgess Powell Kaden Hartman of Virginia Beach is 13-years-old and lives with Niemann-Pick disease, a condition known colloquially as Child’s Alzheimer’s. There are approximately 500 to 100 cases of diagnosed NPD today, making it extremely rare. Children with Niemann-Pick disease experience rapid physical …

Gov. Bevin To Announce Launch of Find Help Now Website, Student Opioid Awareness Marketing Competition

FRANKFORT, Ky. (Feb. 1, 2018) – Gov. Matt Bevin will join representatives from the Cabinet for Health and Family Services, the Justice and Public Safety Cabinet and the University of Kentucky’s Injury Prevention and Research Center to announce the launch of FindHelpNowKY.org. The website allows users to search in real-time for a substance use disorder …

The Next Big Brain Cancer Drug Could Come from Marijuana

Sy Mukherjee 9:44 PM Central GW Pharmaceuticals (gwph, +2.63%) is already well on its way to winning the first-ever U.S. approval for a cannabis-derived therapy. But an early trial suggests that these treatments could also be an effective way to fight one of most devastating forms of brain cancers: glioblastoma multiforme. The U.K.-based company unveiled …

The price of a life-saving overdose treatment has increased 680% to $4,500 in the last 3 years

Lydia Ramsey An emergency medication often referred to as an "antidote" for opioid overdoses has been skyrocketing in price over the last few years. The device, the only auto-injector version of naloxone, is called Evzio, and it's made by Kaleo.  Naloxone instantly reverses opioid overdoses by blocking the drug from interacting with the brain’s receptors. …

How A Psychedelic Drug Helps Cancer Patients Overcome Anxiety

December 3, 20167:00 AM ET Robin Marantz Henig   The brilliantly-colored shapes reminded Carol Vincent of fluorescent deep-sea creatures, and they floated past her languidly. She was overwhelmed by their beauty — and then suddenly, as if in a dream, she was out somewhere in deep space instead. "Oh, wow," she thought, overwhelmed all over …

The Bayer-Monsanto Deal Won’t Eat the Cannabis Industry. Yet.

Submitted by Marijuana News on Fri, 09/16/2016 - 08:10   The news that Monsanto is being bought by Bayer probably won’t be well received in the cannabis sector. The deal brings together two research powerhouses that, reportedly, have long eyed cannabis as a possible new business. The worry is that the combined firm will have …

The FDA Just Outlawed Hemp Oil

  VIA/Hemp oil extracts containing CBDs (cannibidiols) are such a threat to the pharmaceutical industry that the FDA is now invoking totally insane justifications for outlawing them. FDA’s own website: “12. Can products that contain cannabidiol be sold as dietary supplements? A. No. Based on available evidence, FDA has concluded that cannabidiol products are excluded …

Historic Federal Summit on Medicine Marijuana Is Slanted By Drug War Agenda

  By David Downs   A seemingly historic medical marijuana summit by several US government health agencies will largely exclude evidence coming from the states that have legalized medical cannabis — another example of entrenched Washington, DC bureaucrats placing politics over science in the marijuana debate. The National Center for Complementary and Integrative Health (NCCIH) …

French drug trial disaster leaves one brain dead, five injured

PARIS | By Matthias Blamont Fri Jan 15, 2016 11:30am EST   An ambulance is seen outside the Emergency Entrance at the CHU de Rennes hospital, in Rennes, France, where six people are in a serious condition after taking part in a medical trial for an unnamed European laboratory to test a new drug, France's …

My reply to the "Opinion" From December 30, 2015 or "pot Should Stay Illegal In Kentucky"…

  Above:  Mary Thomas-Spears talks with Sen. Perry Clark at the "Comfy Tree Symposium" in Louisville in 2014   To:  Bowling Green Daily News,          813 College Street P.O. Box 90012 Bowling Green, KY 42102 Website Link Opinions:  "Pot should stay illegal in Kentucky" From:  Rev. Mary L. Thomas-Spears, Bowling Green, Kentucky  42101 Dear "Pot …

Big Pharma Shaking in Their Boots as 80% of Cannabis Users Give Up Prescriptions Pills for Pot

  By Justin Gardner on January 8, 2016 A new survey conducted by the Centre for Addictions Research of BC helps explain why Big Pharma is so afraid of cannabis. The pharmaceutical and alcohol industries, both powerful influences in Washington, have long lobbied against cannabis legalization in order to protect their profits. However, the tide …